Comprehensive Review of Cancer-Related Diseases and Their Major Types

Main Article Content

Abstract

Cancer represents a broad collection of disorders in which the normal mechanisms controlling cell growth, division and survival become disrupted. Genomic alterations, epigenetic changes and external influences can allow abnormal cells to multiply beyond normal limits. With progression, malignant cells may infiltrate neighbouring tissues and travel to distant organs through metastasis. Important biological features include resistance to programmed cell death, persistent stimulation of blood-vessel formation, genomic instability and reduced recognition by the immune system. The occurrence of cancer differs according to age, sex, geographical region and socioeconomic conditions, making it a major worldwide cause of illness and death. Developments in molecular biology have clarified the roles of oncogenes, tumour-suppressor genes and cellular signalling pathways. These advances have supported more selective treatments and the growth of personalized oncology. Current management may include surgery, radiation, chemotherapy, targeted medicines and immunotherapy. Nevertheless, tumour heterogeneity, treatment resistance and the difficulty of preventing cancer at population level remain important challenges. Continued research is therefore required to improve prevention, diagnosis and treatment outcomes.

References

Mathur G, Nain S, Sharma PK. Cancer: an overview. Academic Journal of Cancer Research. 2015;8(1):1-9.

2. Chandraprasad MS, Dey A, Swamy MK. Introduction to cancer and treatment approaches. In: Paclitaxel. Academic Press; 2022. p. 1-27.

3. Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proceedings of the National Academy of Sciences. 2002;99(10):6567-72.

4. Wunderlich K, Suppa M, Gandini S, Lipski J, White JM, Del Marmol V. Risk factors and innovations in risk assessment for melanoma, basal cell carcinoma, and squamous cell carcinoma. Cancers. 2024;16(5):1016.

5. Goto H, Kiyohara Y, Shindo M, Yamamoto O. Symptoms of and palliative treatment for unresectable skin cancer. Current Treatment Options in Oncology. 2019;20(4):34.

6. Rutkowski P, et al. Skin carcinomas. Oncology in Clinical Practice. 2020;16(4):143-62.

7. Burningham Z, Hashibe M, Spector L, Schiffman JD. The epidemiology of sarcoma. Clinical Sarcoma Research. 2012;2(1):14.

8. Grünewald TG, et al. Sarcoma treatment in the era of molecular medicine. EMBO Molecular Medicine. 2020;12(11):e11131.

9. Davis AS, Viera AJ, Mead MD. Leukemia: an overview for primary care. American Family Physician. 2014;89(9):731-8.

10. Rose-Inman H, Kuehl D. Acute leukemia. Hematology/Oncology Clinics. 2017;31(6):1011-28.

11. Pui CH, Evans WE. Acute lymphoblastic leukemia. New England Journal of Medicine. 1998;339(9):605-15.

12. Nayak LM, Deschler DG. Lymphomas. Otolaryngologic Clinics of North America. 2003;36(4):625-46.

13. Küppers R. The biology of Hodgkin's lymphoma. Nature Reviews Cancer. 2009;9(1):15-27.

14. Lewis WD, Lilly S, Jones KL. Lymphoma: diagnosis and treatment. American Family Physician. 2020;101(1):34-41.

15. Nabors LB, et al. Central nervous system cancers. Journal of the National Comprehensive Cancer Network. 2013;11(9):1114-51.

16. Salari N, et al. The global prevalence of primary central nervous system tumors: a systematic review and metaanalysis. European Journal of Medical Research. 2023;28(1):39.

17. Buckner JC, et al. Central nervous system tumors. Mayo Clinic Proceedings. 2007;82(10):1271-86. 18. Brem SS, et al. Central nervous system cancers. Journal of the National Comprehensive Cancer Network. 2011;9(4):352400.